Skip to content
healthcare.dev

BCG VACCINE

NDC 0052-0603, BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.

Product NDC
0052-0603
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
PERCUTANEOUS
Product type
VACCINE
Marketing category
BLA
Application
BLA103050
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0052-0603 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN50 mg/1

Pharmacologic classes

Actively Acquired Immunity [PE]; BCG Vaccine [CS]; Increased Immunologically Active Molecule Activity [PE]; Increased Macrophage Proliferation [PE]; Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]; Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]; Vaccines, Attenuated [CS]

Package NDCNDC-11Package
0052-0603-02000520603021 VIAL in 1 CARTON (0052-0603-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0052-0603-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0052-0603 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0052-0603 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0052-0603. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.